![Moehs Dexmedetomidine Hydrochloride](https://www.pharmacompass.com/image/flap/moehs-dexmedetomidine-hydrochloride-desktop-headergif-90440.gif)
![Moehs Dexmedetomidine Hydrochloride](https://www.pharmacompass.com/image/flap/moehs-dexmedetomidine-hydrochloride-mobgif-89131.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
EU WC
Listed Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
https://www.globenewswire.com/news-release/2024/07/16/2913610/0/en/BioXcel-Therapeutics-Announces-Preliminary-Estimated-Unaudited-Second-Quarter-Net-Revenues-from-Sales-of-IGALMI-dexmedetomidine-Sublingual-Film.html
https://www.globenewswire.com/news-release/2024/06/25/2903646/0/en/BioXcel-Therapeutics-Announces-Positive-Topline-Results-from-Post-Marketing-Requirement-Study-Evaluating-PRN-Treatment-of-IGALMI-dexmedetomidine-Sublingual-Film-for-Agitation-Assoc.html
https://www.globenewswire.com//news-release/2023/10/30/2769033/0/en/BioXcel-Therapeutics-Receives-Permanent-J-Code-for-IGALMI-dexmedetomidine-Sublingual-Film-from-Centers-for-Medicare-Medicaid-Services.html
https://www.globenewswire.com//news-release/2023/10/04/2754431/0/en/BioXcel-Therapeutics-Provides-Update-on-Recent-Developments-for-Late-Stage-Clinical-Programs-and-Expansion-of-IP-Portfolio-for-IGALMI-dexmedetomidine-Sublingual-Film.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217308
https://www.prnewswire.com/news-releases/piramal-critical-care-launches-first-to-market-generic-zinc-sulfate-injection-in-the-us-301608664.html
https://www.globenewswire.com/news-release/2022/08/01/2489261/0/en/BioXcel-Therapeutics-Announces-NIH-NIDA-Grant-to-Columbia-University-to-Support-Further-Studies-of-BXCL501-Sublingual-Dexmedetomidine-for-Treating-Opioid-Withdrawal.html
https://endpts.com/psych-and-neuro-rd-notch-a-win-as-bioxcel-gets-fda-approval-for-schizophrenia-bipolar-disorder-related-agitation/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214794
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-16-2020-1608097779.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210321
https://www.indiainfoline.com/article/news-top-story/aurobindo-pharma-receives-usfda-approval-for-dexmedetomidine-hcl-in-0-9-sodium-chloride-injection-120120900452_1.html
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/aurobindo-pharma-gets-usfda-nod-for-sedative-drug/articleshow/79637842.cms
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212857
https://www.pharmacompass.com/pdf/news/fresenius-kabi-issues-voluntary-nationwide-recall-of-a-single-lot-of-dexmedetomidine-hydrochloride-1606565407.pdf
https://www.firstwordpharma.com/node/1768448?tsid=5
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208266
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-2-2020-1599053980.pdf
https://www.globenewswire.com/news-release/2020/06/11/2046758/0/en/BioXcel-Therapeutics-Announces-First-Patient-Enrolled-in-Phase-1b-2-RELEASE-Trial-of-BXCL501-for-the-Treatment-of-Opioid-Withdrawal-Symptoms.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207551
https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-daily-roundup-may-21-2020
https://www.raps.org/news-and-articles/news-articles/2020/4/fda-reports-more-shortages-of-drugs-used-to-put-co
http://www.pharmatimes.com/news/five_meds_recommended_in_final_2019_chmp_meeting_1320403
https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-9-12-december-2019
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212791
https://www.pharmacompass.com/pdf/news/Enforcement-Report-Week-of-May-1-2019-1556686753.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208129
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208532
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206798
https://www.pharmacompass.com/pdf/news/precedex-dexmedetomidine-hcl-baxter-healthcare-corporation-v-hospira-1520247044.pdf
https://www.pharmacompass.com/pdf/news/precedextm-dexmedetomidine-hydrochloride-hospira-v-gland-pharma-1517811100.pdf
https://www.pharmacompass.com/pdf/news/precedextm-dexmedetomidine-hydrochloride-hospira-v-jiangsu-hengrui-medicine-1517810972.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205272
https://www.pharmacompass.com/pdf/news/precedextm-dexmedetomidine-hydrochloride-hospira-inc-v-fresenius-kabi-usa-1510550169.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209065
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203773
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205046
https://www.pharmacompass.com/pdf/news/actaviss-generic-dexmedetomidine-hcl-approved-in-us-1476969954.pdf
https://www.pharmacompass.com/pdf/news/hq-spclt-pharmas-dexmedetomidine-hydrochloride-approved-in-us-1474461034.pdf
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/aurobindo-gets-final-usfda-nod-for-pre-surgery-sedation-drug/articleshow/51453728.cms
https://www.pharmacompass.com/pdf/news/accord-hlthcares-generic-dexmedetomidine-hcl-approved-in-us-1455705915.pdf
https://www.pharmacompass.com/pdf/news/fresenius-kabis-generic-dexmedetomidine-hydrochloride-approved-in-us-as-sedative-1443094654.pdf
http://www.firstwordpharma.com/node/1299982?tsid=28®ion_id=6#axzz3fm2VkTKN
http://www.fiercepharmamanufacturing.com/story/attix-pharmaceuticals-recalls-hundreds-apis-us/2015-04-30